Document is current
Any future updates will be listed below
-
Authors
Sakuma, Maki http://orcid.org/0000-0001-7579-6232
Blombery, Piers
Meggendorfer, Manja http://orcid.org/0000-0002-9038-3265
Haferlach, Claudia http://orcid.org/0000-0002-6333-5049
Lindauer, Markus
Martens, Uwe M.
Kern, Wolfgang http://orcid.org/0000-0002-6452-2874
Haferlach, Torsten http://orcid.org/0000-0003-0196-2837
Walter, Wencke http://orcid.org/0000-0002-5083-9838
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (953407)
Torsten Haferlach Leukämiediagnostik Stiftung, Grant Support
- License Information
-
More Information
Article History
Received: 30 November 2022
Revised: 13 February 2023
Accepted: 15 February 2023
First Online: 23 February 2023
Competing interests
: CH, WK, and TH declare part ownership of Munich Leukemia Laboratory (MLL). MS, MM and WW are employed by the MLL.
